Business Wire

QUINTIQ

12.5.2016 09:02:55 CEST | Business Wire | Press release

Share
Virgin Atlantic Airways Selects Quintiq to Optimize Ground Staff Planning for the Ultimate Passenger Experience

Quintiq, a Dassault Systèmes company and global leader in supply chain planning and optimization (SCP&O), announced today that its application has been selected by Virgin Atlantic Airways to plan and optimize ground staff at London Heathrow Airport Terminal 3.

Virgin Atlantic’s mission to embrace the human spirit and let it fly comes to life at London Heathrow Airport Terminal 3, the hub of the airline’s operations. Prior to Quintiq, Virgin Atlantic planned its customer-facing terminal staff with a standalone system and spreadsheets. The airline found it challenging in staff planning terms to realize its vision of offering the best passenger experience while keeping staff happy and costs low. With Quintiq, Virgin Atlantic adopts an innovative demand-driven approach to staff planning that takes its lead from the flight schedule. This approach covers all planning horizons and rostering of ground staff. Virgin Atlantic’s planners can combine a future flight schedule with the predicted passenger numbers to model operations and identify staffing requirements. Queuing at check-in is better managed, as the system suggests the number of check-in desks needed. With increased visibility of demand, planners evaluate headcount requirements of future schedules. Planners are equipped to make decisions on the day of operations to make sure that scheduled coverage meets the demand derived from the flight schedule. This results in optimal coverage at all times.

The Quintiq advantage is particularly powerful in cases of a sudden change, such as a flight cancellation. In such cases, the application alerts planners to the impact of the disruption and provide re-planning support. Quintiq also helps Virgin Atlantic cut down on overtime costs by predicting shortages days in advance, enabling the planners to adjust shift start times rather than extending shifts on the day itself.

“The desire to provide every Virgin Atlantic passenger with a fantastic experience drives everything we do. This is no different,” said John Bell, General Manager UK Airports, Virgin Atlantic. “With Quintiq supporting us to improve operational efficiencies, deliver cost savings, and keep our staff happy, we’ll be able to focus on innovating and creating new opportunities to serve our passengers even better.”

For more information, visit www.quintiq.com or follow Quintiq on Twitter , Facebook , LinkedIn and YouTube .

Contact:

North America Enquiries
Racepoint Group
Brittany Falconer
Tel: +1 617 624 3242
quintiq@racepointgroup.com
or
EMEA Enquiries
Weber Shandwick
Sophie Waterfield
Tel: +44 20 7067 0728
quintiq@webershandwick.com

Link:

ClickThru

Social Media:

https://www.facebook.com/Quintiq

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Investment Is Surging, but Businesses Are Struggling to Prove the Value, HTEC Global Study Finds15.10.2026 10:42:00 CEST | Press release

Research among 1,500 C-suite executives finds 77% believe people and processes now constrain AI value more than technology HTEC, a global product engineering and AI transformation company, today launches The HTEC AI Value Realization Report 2026, revealing a new challenge emerging as organizations move beyond AI experimentation: investment is accelerating faster than many companies’ ability to measure, govern and consistently realize its value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015407055/en/ HTEC, a global product engineering and AI transformation company, today launches The HTEC AI Value Realization Report 2026, revealing a new challenge emerging as organizations move beyond AI experimentation: investment is accelerating faster than many companies’ ability to measure, govern and consistently realize its value. The independent study finds that 79% of organizations have increased AI investment over the past ye

Too Good To Go Expands Its Marketplace Beyond Food15.10.2026 09:30:00 CEST | Press release

Too Good To Go, the world's largest marketplace for surplus food, today announced that it is expanding its Marketplace beyond food, enabling retailers to redistribute surplus across personal care — including skincare, haircare, oral care and beauty products — pet care, flowers and plants, nutrition and supplements, and home, initially spanning cleaning and laundry products and décor. More than 8,500 stores already supply products across these areas, around one third of which were already working with Too Good To Go to redistribute surplus food. “In today’s society, we have built incredibly efficient processes for producing and selling things at scale, creating abundance, but we have not built the same efficiency into making sure what is left over gets used. As our lives have become more convenient, we have become less conscious of what those things are worth. We used to finish what was on the plate, find a use for what we had and instinctively pause before throwing something away. Too

Flowdesk Europe Receives Payment Institution Authorization from the ACPR Under PSD215.10.2026 09:30:00 CEST | Press release

The authorization allows Flowdesk Europe to provide custody and transfer services for fiat-denominated stablecoins, complementing its MiCA CASP authorization and regulated offering for European clients. Flowdesk, a global liquidity provider and digital asset trading and infrastructure provider, today announced that its European entity, Flowdesk Europe, has been authorized as a Payment Institution by the French Prudential Supervision and Resolution Authority, l'Autorité de contrôle prudentiel et de résolution (ACPR), under the second Payment Services Directive (PSD2). The authorization allows Flowdesk Europe to provide custody and transfer services for e-money tokens (EMTs), the fiat-referenced stablecoins regulated under the Markets in Crypto-Assets (MiCA) regulation, to its clients across the European Union. The authorization follows the entity’s Crypto-Asset Service Provider (CASP) authorization received from the Autorité des Marchés Financiers (AMF) under MiCA at the end of June thi

From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 09:00:00 CEST | Press release

Industry leaders get together to explore how trusted AI, Agentic Intelligence and automation are transforming risk management, accelerating autonomous network operations and unlocking new opportunities for value creation Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use case

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye